MRPS16通过PI3K/AKT/Frataxin信号轴促进肺腺癌的生长
Zaixing Cheng1, Kaming Xue2, Cui Xiong3
1Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Journal of cellular and molecular medicine
|March 20, 2024
概括
线粒体核糖体蛋白S16 (MRPS16) 促进喉状细胞癌 (LAUD) 的进展和入侵. 针对MRPS16可能为LAUD患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 线粒体核糖体蛋白S16 (MRPS16) 与癌症有关,但其在喉状细胞癌 (LAUD) 中的作用尚不清楚.
- 研究MRPS16的功能对于理解LAUD的发病因子和确定潜在的治疗点至关重要.
研究的目的:
- 阐明MRPS16在喉状细胞癌 (LAUD) 的发展和进展中的作用和机制.
- 评估MRPS16作为LAUD中的预后生物标志物和治疗标.
主要方法:
- 使用定量实时PCR (qRT-PCR),西部Blot (WB) 和免疫组织化学 (IHC) 来评估MRPS16表达.
- 进行了功能测定和动物实验,以确定MRPS16对LAUD进展的影响.
- 通过Western Blot.研究了MRPS16对PI3K/AKT/Frataxin信号通路的影响.
主要成果:
- 发现MRPS16在LAUD组织上升调节,与晚期TNM阶段和不良临床结果相关.
- MRPS16显著促进LAUD细胞生长,迁移和入侵,部分是通过激活PI3K/AKT/Frataxin通路.
- 击败MRPS16导致弗拉塔克辛的过度表达,这部分恢复了瘤细胞的增殖,迁移和入侵.
结论:
- MRPS16作为一个独立的预后因素,促进LAUD的侵略性表型.
- 向MRPS16为治疗喉状细胞癌提供了潜在的治疗策略.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
429
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
